It was a mistake that cost 300,000 lives.
A treatment made from the blood of recovered Covid-19 patients seemed promising in March. Today … well, it’s still just promising.
Indoor air experts think: Sure, maybe. Why the hell not? We convinced the CEO of an air filter company to give it a try.
The movement of demonstrators echoes the fluid collective responses of the animal world, as groups respond to threats and signal across large spaces.
Covid-19 is a new disease. Remdesivir is an experimental drug. How can scientists tell if it’s successful while the world shifts around them?
Two more studies prove that the much-hyped antimalarial doesn’t treat Covid-19.
In just three months, one British research team identified the first life-saving drug of the pandemic (and helped cancel hydroxychloroquine).
Throughout history, US presidents have fudged the truth about their health. But all the data voters need about Trump is already out for everyone to see.
Public health experts think Covid-19 risk is lower outside, and restaurateurs want to fill tables. It’s an easy solution—except for all the hard parts.
Sure, large crowds already carry a risk of transmission. It’s just worse when you teargas people, make them cough on each other, and bus them to jail.